Health and health behaviors in HIV-infected jail inmates, 1999 and 2005

AIDS Patient Care and STDs

Volumn 22, Issue 3, 2008, Pages 221-231

  White, Mary C ^a,d   Tulsky, Jacqueline P ^a   Estes, Milton ^b   Jamison, Ross ^a   Long, Heather L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^c Crossroads Inc: A Residential Program for Women Who Have Been Incarcerated   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRISON; QUALITY OF LIFE; RISK FACTOR; SELF REPORT; SOCIAL SUPPORT;

ADULT; CONDOMS; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; PRISONERS; RISK-TAKING; SAN FRANCISCO; SOCIAL CLASS; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 40749137376     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0043     Document Type: Article

References (41)

1. Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: Health interventions in criminal justice settings. Health Educ Behav 1998;25:99-120.
2. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health 2002;92:1789-1794.
3. National Commission on Correctional Health Care. The Health Status of Soon-to-be-Released Inmates: A Report To Congress. Volume 1 and 2. Chicago: National Commission on Correctional Health Care, March 2002.
4. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan T. Human immunodeficiency virus in correctional facilities: A review. Clin Infect Dis 2002;35:305-312.
5. Conklin TJ, Lincoln T, Turnhill RW. Self-reported health and prior health behaviors of newly admitted correctional inmates. Am J Public Health 2000;90:1939-1941.
6. MacGowan RJ, Margolis A, Gaiter J, et al. Predictors of risky sex of young men after release from prison. Int J STD AIDS 2003;14:519-523.
7. Margolis AD, MacGowan RJ, Grinstead O, Sosman J, Kashif I, Flanigan TP; Project START Study Group. Unprotected sex with multiple partners: Implications for HIV prevention among young men with a history of incarceration. Sex Transm Dis 2006;33:175-180.
8. Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: Reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis 2004;38:1754-1766
9. Mahon N. New York Inmates' HIV risk behaviors: The implications for prevention policy and programs. Am J Public Health 1996;86:1211-1215.
10. Altice FL, Mostashari F, Selwyn PA, et al. Predictors of HIV infection among newly sentences male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:444-453.
11. Mostashari F, Riley E, Selwyn PA, Altice FL. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:341-348.
12. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
13. Flanigan TP, Rich JD, Spaulding A. HIV care among incarcerated persons: A missed opportunity. AIDS 1999;13:2475-2476.
14. Sabin KM, Frey RL, Horsley R, Greby SM. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992-1998. J Urban Health 2001;78:241-255.
15. Braithwaite RL, Arriola KRJ. Male prisoners and HIV prevention: A call for action ignored. Am J Public Health 2003;93:759-763.
16. Basu S, Smith-Rohrberg D, Hanck S, Altice FL. HIV testing in correctional institutions: evaluating existing strategies, setting new standards. AIDS Public Policy J 2005;20:3-24.
17. Varghese B, Peterman TA. Cost-effectiveness of HIV counseling and testing in US prisons. J Urban Health 2001;78:304-312.
18. Wohl DA, Rosen D, Kaplan AH. HIV and incarceration: dual epidemics. AIDS Read 2006;16:247-250, 257-260.
19. Braithwaite RL, Stephens TT, Treadwell HM, Braithwaite K, Conerly R. Short-term impact of an HIV risk reduction intervention for soon-to-be released inmates in Georgia. J Health Care Poor Underserved 2005;16(4 Suppl B):130-139.
20. Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health 2001;78:279-289.
21. Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep 2005;120:84-88.
22. Sanchez T, Finlayson T, Drake A, et al. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: Men who have sex with men, November 2003-April 2005. MMWR Morb Mortal Wkly Rep 2006;55:1-16.
23. Aidala AA, Lee G, Howard JM, Caban M, Abramson D, Messeri P. HIV-positive men sexually active with women: Sexual behaviors and sexual risks. J Urban Health 2006;83:637-655.
24. Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health 2006;83:86-100.
25. McCoy CB, Metsch LR, Comerford M, Zhao W, Coltes AJ, Messiah SE. Trends of HIV risk behaviors in a cohort of injecting drug users and their sex partners in Miami, Florida, 1988-1998. AIDS Behav 2005;9:187-199.
26. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care 1991;29:786-798.
27. Ware JE. SF-36 Health Survey Update. Spine 2000;25:3130-3139.
28. Centers for Disease Control and Prevention. Advancing HIV Prevention. Strategy 3: Prevent New Infections by Working with People Diagnosed with HIV and Their Partners. www.cdc.gov/hiv/topics/prev_prog/AHP/AHP-Strategy3.htm (Last accessed November 29, 2006).
29. Oleski M. The effect of indefinite pretrial incarceration on the anxiety level of an urban jail population. J Clin Psychol 1977;33:1006-1008.
30. Blanc A, Lauwers V, Telmon N, Rouge D. The effect of incarceration on prisoners' perception of their health. J Community Health 2001;26:367-381.
31. Reinhardt V, Rogers R. Differences in anxiety between first-time and multiple-time inmates: A multicultural perspective. J Am Acad Psychiatry Law 1998;26:375-382.
32. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed Altruism" and "Partner Restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr 2004;35:158-166.
33. Mehta SH, Galai N, Astemborski J, et al. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). J Acquir Immune Defic Syndr 2006;43:368-372.
34. Centers for Disease Control and Prevention (CDC). Methamphetamine use and HIV risk behaviors among heterosexual men - Preliminary results from five northern California counties, December 2001-November 2003. MMWR 2006;55:273-277.
35. Purcell DW, Mizuno Y, Metsch LR, et al. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: Associations by partner type and partner serostatus. J Urban Health 2006;83:656-668.
36. Semaan S, Des Jarlais DC, Sogolow E, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr 2002;30(Suppl 1):S73-S93.
37. Semaan S, Kay L, Strouse D, et al. A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr 2002;30(Suppl 1):S30-S50.
38. Copenhaver MM, Johnson BT, Lee I-C, Harmon JT, Carey MP, and the SHARP Research Team. Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. J Subst Abuse Treat 2006;31:163-171.
39. Stockman JK, Schwarz SK, Butler LM, et al. HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr 2004;35:432-433.
40. Steward WT, Koester KA, Myers JJ, Morin SF. Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings. AIDS Behav 2006;10:3-12.
41. Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee SA. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. AIDS Behav 2005;9:289-299.